| | 1062368-62-0 Basic information More.. |
| Product Name: | LDN-193189 HCl | | Synonyms: | 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline hydrochloride;4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyriMidin-3-yl)quinoline HCl;LDN193189 (Hydrochloride);4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline hydrochloride (1:1);LDN-193189 HCl;LDN193189 hydrochloride, 98%, a selective BMP type I receptor kinases inhibitor;LDN-193189 HCL;LDN 193189 HCL;LDN 193189 HYDROCHLORIDE;LDN-193189 HYDROCHLORIDE;LDN-193189 HCL;LDN 193189 HCL | | CAS: | 1062368-62-0 | | MF: | C25H23ClN6 | | MW: | 442.94332 | | EINECS: | | | Mol File: | 1062368-62-0.mol |  |
Use
LDN-193189 HCl has been used to inhibit BMP type I receptor activity to study the pathogenesis of fibrodysplasia ossificans progressive, a congenital hyperossification disorder, and to examine the role of osteogenesis in prostate tumor metastases in bone.
- LDN-193189 HCl
-
- US $37.00-72.00 / mg
- 2025-05-05
- CAS:1062368-62-0
- Min. Order:
- Purity: 99.53%
- Supply Ability: 10g
- LDN-193189 HCl
-
- US $1.00 / g
- 2019-12-24
- CAS:1062368-62-0
- Min. Order: 1g
- Purity: 99.99%
- Supply Ability: 200kg
|
|
1062368-62-0
Recommend Suppliers |
|